This clinical diagnostic group has seen its shares soar on the back of Covid-19 testing, but will it make the most of this unique opportunity?
Breedon Group: results better than expected
Breedon (LON:BREE), the leading construction materials group, has continued to deliver an encouraging trading performance since demand began to return in early May. Revenues for the first eight months of the year were £531m (2019: £624m), including a one-month contribution from the recently acquired CEMEX assets in the UK.
Unlike many businesses they are now able to reinstate guidance for the 2020 financial year and currently anticipate delivering second-half underlying EBIT…
Access the all latest company comments on Investor's Champion.
Not yet registered? It's free to register. Register now.
Register on Investor's Champion
Access the all latest company comments on Investor's Champion.
Premium Content
Premium content provides more in-depth information on fascinating investment stories and research to help make your money go further.
Access Premium Content through individual credits (we only want you to read what you are interested in) or through an annual subscription, which works out as only 25p per day – a small price to guide you through the investing maze!
Subscription
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
In depth coverage of many of the world’s great companies
Breaking news on potential upcoming disasters
Unique insights from our top research team
Credits
Get access to our premium content for as little as £3.20 per article.